IDH1 and central nervous system cancer: Despite numerous studies that show different approaches to obtain and use patient-derived glioma cells for treatment modeling, most of them describe only glioblastoma features, lacking the exhibition of other types of gliomas such as IDH-mutant astrocytoma and oligodendroglioma [92].